A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Novartis
Related studies linked through entity extraction aliases.
A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone
- Status
- COMPLETED
- Phase
- PHASE3
Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone
- Status
- COMPLETED
- Phase
- PHASE3
A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone
- Status
- COMPLETED
- Phase
- PHASE3
Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension
- Status
- TERMINATED
- Phase
- PHASE3
A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
- Status
- COMPLETED
- Phase
- PHASE4
To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain
- Status
- COMPLETED
- Phase
- PHASE4
Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout
- Status
- COMPLETED
- Phase
- PHASE4
Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over
- Status
- COMPLETED
- Phase
- PHASE2
A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery
- Status
- COMPLETED
- Phase
- PHASE4
Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia
- Status
- TERMINATED
- Phase
- PHASE4
Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia
- Status
- TERMINATED
- Phase
- PHASE4